Skip to main content
. 2026 Mar 19;18(3):379. doi: 10.3390/pharmaceutics18030379
AEs adverse events
CCK-BR cholecystokinin B receptor
CTCAE Common Terminology Criteria for Adverse Events
EMT epithelial-to-mesenchymal transition
ER epitope retrieval
FFPE Formalin-Fixed Paraffin-Embedded
GEEs Generalized Estimating Equations
GEM-NAB-P gemcitabine/nab-paclitaxel
GPCRs G-protein-coupled receptors
MASH metabolic dysfunction-associated steatohepatitis
H&E hematoxylin and eosin
MPQ McGill Pain Questionnaire
NK natural killer
PDAC pancreatic ductal adenocarcinoma
PSCs pancreatic stellate cells
RT room temperature
TAMs tumor-associated macrophages
TID three times daily
TILs tumor-infiltrating lymphocytes
TME tumor microenvironment
ULN upper limit of normal